Author:
Van Glabbeke M,van Oosterom A.T,Steward W,Verweij J,Mouridsen H
Reference16 articles.
1. EORTC New Drug Development Office coordinating and monitoring programme for phase I and II trials with new anticancer agents;Schwartsmann;Eur J Cancer,1991
2. Phase II studies: wrong doses, wrong patients?;Judson;Eur J Cancer,1991
3. Prognostic of response and risk of toxicity in phase II trials;Van Glabbeke;Invest New Drugs,1984
4. To what extent do phase II trial results depend on the selection of patients?;Van Glabbeke,1984
5. Criteria of response used in clinical trials of chemotherapy;Tonkin;J Clin Oncol,1985
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献